(Q43703212)

26 November 2017

Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness (English)

1 reference

Trypanosoma brucei gambiense infectious disease

26 November 2017

0 references

0 references

0 references

African trypanosomiasis

0 references

author

Theo Niyonsenga

4

1 reference

26 November 2017

Pépin J

1

1 reference

26 November 2017

Milord F

2

1 reference

26 November 2017

Khonde AN

3

1 reference

26 November 2017

Loko L

5

1 reference

26 November 2017

Mpia B

6

1 reference

26 November 2017

De Wals P

7

1 reference

26 November 2017

1 January 1995

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

26 November 2017

1 reference

26 November 2017

89

1 reference

26 November 2017

1

1 reference

26 November 2017

92-97

1 reference

Four years' experience of melarsen oxide/BAL in the treatment of late-stage Rhodesian sleeping sickness

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2895%2990673-8

Present status of chemotherapy and chemopropylaxis of human trypanosomiasis in the Eastern Hemisphere

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2895%2990673-8

Pharmacokinetic properties of the trypanocidal drug melarsoprol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2895%2990673-8

Subcurative chemotherapy and fatal post-treatment reactive encephalopathies in African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2895%2990673-8

African trypanosomiasis: more aggressive treatment or more aggressive research?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2895%2990673-8

Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2895%2990673-8

African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2895%2990673-8

The treatment of sleeping sickness (mainly due to Trypanosoma rhodesiense) with melarsoprol. I. Reactions observed during treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2895%2990673-8

Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2895%2990673-8

10.1016/0035-9203(95)90673-8

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference